Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
Details for Australian Patent Application No. 2005230401 (hide)
International Classifications
Event Publications
7 September 2006 PCT application entered the National Phase
PCT publication WO2005/097068 Priority application(s): WO2005/097068
27 November 2008 Application Accepted
Published as AU-B-2005230401
26 March 2009 Standard Patent Sealed
26 April 2012 Assignment Registered
Novartis AG The patent has been assigned to MEDA Pharma S.a.r.l.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005230402-Deferasirox dispersible tablets
2005230400-Use of cyclosporins for treatment of cerebral ischemia and brain and spinal cord injury
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser